Form 4 for MTVA MetaVia Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0000899140-24-001036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-20 | 2024-09-12 | MTVA | DONG-A ST CO., LTD | 10% | S - Sale | $3.75 | -407 | 5.35M | -0.0% | -$1,526 |
| DM | 2024-09-20 | 2024-09-18 | MTVA | DONG-A ST CO., LTD | 10% | P - Purchase | — | +6.36M | 2.54M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | S | D | 407 | $3.75 | 5,347,792 | D | — | — | (F1) Reporting Person's sale of 407 shares of Common Stock at a price per share of $3.75 occurred on September 12, 2024. |
| 2 | Derivative | Warrants to Purchase Common Stock | 2024-09-18 | P | A | 3,816,795 | — | 3,816,795 | D | $3.93 · 2024-09-18 to 2029-09-18 | 3,816,795 Common Stock | (F2) On June 13, 2024, the Issuer issued (i) Series A Warrants to purchase up to an aggregate of 2,544,530 shares of the Issuer's common stock (the "Series A Warrant Shares") and (ii) 3,816,795 Series B Warrants to purchase up to an aggregate of 3,816,795 shares of the Issuer's common stock (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants"), to the reporting person pursuant to a securities purchase agreement dated the same date (the "Purchase Agreement"), in connection with a private placement of securities by the Issuer to certain investors. The issuance of the Warrants under the Purchase Agreement was subject to stockholder approval under applicable NASDAQ rules, which was obtained at a special meeting of the Issuer's stockholders held on September 18, 2024. (F4) These warrants expire on the earlier of (i) the five years anniversary of September 18, 2024 and (ii) the six months anniversary following the date on which the Issuer publicly announce the receiving of positive Phase 1, Part 3 data readout for DA-1726. |
| 3 | Derivative | Warrants to Purchase Common Stock | 2024-09-18 | P | A | 2,544,530 | — | 2,544,530 | D | $3.93 · 2024-09-18 to 2025-09-18 | 2,544,530 Common Stock | (F2) On June 13, 2024, the Issuer issued (i) Series A Warrants to purchase up to an aggregate of 2,544,530 shares of the Issuer's common stock (the "Series A Warrant Shares") and (ii) 3,816,795 Series B Warrants to purchase up to an aggregate of 3,816,795 shares of the Issuer's common stock (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants"), to the reporting person pursuant to a securities purchase agreement dated the same date (the "Purchase Agreement"), in connection with a private placement of securities by the Issuer to certain investors. The issuance of the Warrants under the Purchase Agreement was subject to stockholder approval under applicable NASDAQ rules, which was obtained at a special meeting of the Issuer's stockholders held on September 18, 2024. (F3) These warrants expire on the earlier of (i) the twelve months anniversary of September 18, 2024, and (ii) the 60th day following the date on which the Issuer publicly announce the receiving of positive Phase 1 MAD data readout for DA-1726. |